Cargando…
Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme
BACKGROUND: Delayed presentation of pulmonary TB (PTB) patients for treatment from onset of symptoms remains a threat to controlling individual disease progression and TB transmission in the community. Currently, there is insufficient information about treatment delays in Zimbabwe, and we therefore...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314739/ https://www.ncbi.nlm.nih.gov/pubmed/25631667 http://dx.doi.org/10.1186/s12889-015-1437-7 |
_version_ | 1782355357256908800 |
---|---|
author | Takarinda, Kudakwashe C Harries, Anthony D Nyathi, Barnet Ngwenya, Mkhokheli Mutasa-Apollo, Tsitsi Sandy, Charles |
author_facet | Takarinda, Kudakwashe C Harries, Anthony D Nyathi, Barnet Ngwenya, Mkhokheli Mutasa-Apollo, Tsitsi Sandy, Charles |
author_sort | Takarinda, Kudakwashe C |
collection | PubMed |
description | BACKGROUND: Delayed presentation of pulmonary TB (PTB) patients for treatment from onset of symptoms remains a threat to controlling individual disease progression and TB transmission in the community. Currently, there is insufficient information about treatment delays in Zimbabwe, and we therefore determined the extent of patient and health systems delays and their associated factors in patients with microbiologically confirmed PTB. METHODS: A structured questionnaire was administered at 47 randomly selected health facilities in Zimbabwe by trained health workers to all patients aged ≥18 years with microbiologically confirmed PTB who were started on TB treatment and entered in the health facility TB registers between 01 January and 31 March 2013. Multivariate logistic regression was used to calculate adjusted odds ratios (aOR) and 95% confidence intervals (CIs) for associations between patient/health system characteristics and patient delay >30 days or health system delay >4 days. RESULTS: Of the 383 recruited patients, 211(55%) were male with an overall median age of 34 years (IQR, 28-43). There was a median of 28 days (IQR, 21-63) for patient delays and 2 days (IQR, 1-5) for health system delays with 184 (48%) and 118 (31%) TB patients experiencing health system delays >30 days and health system delays >4 days respectively. Starting TB treatment at rural primary healthcare vs district/mission facilities [aOR 2.70, 95% CI 1.27-5.75, p = 0.01] and taking self-medication [aOR 2.33, 95% CI 1.23-4.43, p = 0.01] were associated with encountering patient delays. Associated with health system delays were accessing treatment from lower level facilities [aOR 2.67, 95% CI 1.18-6.07, p = 0.019], having a Gene Xpert TB diagnosis [aOR 0.21, 95% CI 0.07-0.66, p = 0.008] and >4 health facility visits prior to TB diagnosis [(aOR) 3.34, 95% CI 1.11-10.03, p = 0.045]. CONCLUSION: Patient delays were longer and more prevalent, suggesting the need for strategies aimed at promoting timely seeking of appropriate medical consultation among presumptive TB patients. Health system delays were uncommon, suggesting a fairly efficient response to microbiologically confirmed PTB cases. Identified risk factors should be explored further and specific strategies aimed at addressing these factors should be identified in order to lessen patient and health system delays. |
format | Online Article Text |
id | pubmed-4314739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43147392015-02-04 Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme Takarinda, Kudakwashe C Harries, Anthony D Nyathi, Barnet Ngwenya, Mkhokheli Mutasa-Apollo, Tsitsi Sandy, Charles BMC Public Health Research Article BACKGROUND: Delayed presentation of pulmonary TB (PTB) patients for treatment from onset of symptoms remains a threat to controlling individual disease progression and TB transmission in the community. Currently, there is insufficient information about treatment delays in Zimbabwe, and we therefore determined the extent of patient and health systems delays and their associated factors in patients with microbiologically confirmed PTB. METHODS: A structured questionnaire was administered at 47 randomly selected health facilities in Zimbabwe by trained health workers to all patients aged ≥18 years with microbiologically confirmed PTB who were started on TB treatment and entered in the health facility TB registers between 01 January and 31 March 2013. Multivariate logistic regression was used to calculate adjusted odds ratios (aOR) and 95% confidence intervals (CIs) for associations between patient/health system characteristics and patient delay >30 days or health system delay >4 days. RESULTS: Of the 383 recruited patients, 211(55%) were male with an overall median age of 34 years (IQR, 28-43). There was a median of 28 days (IQR, 21-63) for patient delays and 2 days (IQR, 1-5) for health system delays with 184 (48%) and 118 (31%) TB patients experiencing health system delays >30 days and health system delays >4 days respectively. Starting TB treatment at rural primary healthcare vs district/mission facilities [aOR 2.70, 95% CI 1.27-5.75, p = 0.01] and taking self-medication [aOR 2.33, 95% CI 1.23-4.43, p = 0.01] were associated with encountering patient delays. Associated with health system delays were accessing treatment from lower level facilities [aOR 2.67, 95% CI 1.18-6.07, p = 0.019], having a Gene Xpert TB diagnosis [aOR 0.21, 95% CI 0.07-0.66, p = 0.008] and >4 health facility visits prior to TB diagnosis [(aOR) 3.34, 95% CI 1.11-10.03, p = 0.045]. CONCLUSION: Patient delays were longer and more prevalent, suggesting the need for strategies aimed at promoting timely seeking of appropriate medical consultation among presumptive TB patients. Health system delays were uncommon, suggesting a fairly efficient response to microbiologically confirmed PTB cases. Identified risk factors should be explored further and specific strategies aimed at addressing these factors should be identified in order to lessen patient and health system delays. BioMed Central 2015-01-29 /pmc/articles/PMC4314739/ /pubmed/25631667 http://dx.doi.org/10.1186/s12889-015-1437-7 Text en © Takarinda et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Takarinda, Kudakwashe C Harries, Anthony D Nyathi, Barnet Ngwenya, Mkhokheli Mutasa-Apollo, Tsitsi Sandy, Charles Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme |
title | Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme |
title_full | Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme |
title_fullStr | Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme |
title_full_unstemmed | Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme |
title_short | Tuberculosis treatment delays and associated factors within the Zimbabwe national tuberculosis programme |
title_sort | tuberculosis treatment delays and associated factors within the zimbabwe national tuberculosis programme |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314739/ https://www.ncbi.nlm.nih.gov/pubmed/25631667 http://dx.doi.org/10.1186/s12889-015-1437-7 |
work_keys_str_mv | AT takarindakudakwashec tuberculosistreatmentdelaysandassociatedfactorswithinthezimbabwenationaltuberculosisprogramme AT harriesanthonyd tuberculosistreatmentdelaysandassociatedfactorswithinthezimbabwenationaltuberculosisprogramme AT nyathibarnet tuberculosistreatmentdelaysandassociatedfactorswithinthezimbabwenationaltuberculosisprogramme AT ngwenyamkhokheli tuberculosistreatmentdelaysandassociatedfactorswithinthezimbabwenationaltuberculosisprogramme AT mutasaapollotsitsi tuberculosistreatmentdelaysandassociatedfactorswithinthezimbabwenationaltuberculosisprogramme AT sandycharles tuberculosistreatmentdelaysandassociatedfactorswithinthezimbabwenationaltuberculosisprogramme |